Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series

Non-platinum single agents are usually used for patients with platinum-resistant recurrent ovarian cancers (ROC). However, the efficacy of these drugs is limited. The aim of the present study was to evaluate the efficacy and adverse events (AE) of combination therapy with irinotecan and platinum (CP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Shibutani, Takashi, Takano, Masashi, Miyamoto, Morikazu, Yoshikawa, Tomoyuki, Aoyama, Tadashi, Soyama, Hiroaki, Hirata, Junko, Suzuki, Ayako, Sasa, Hidenori, Furuya, Kenichi
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5492769/
https://ncbi.nlm.nih.gov/pubmed/28685075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1258
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados